Cargando…
A Huntingtin Peptide Inhibits PolyQ-Huntingtin Associated Defects
BACKGROUND: Huntington’s disease (HD) is caused by the abnormal expansion of the polyglutamine tract in the human Huntingtin protein (polyQ-hHtt). Although this mutation behaves dominantly, huntingtin loss of function also contributes to HD pathogenesis. Indeed, wild-type Huntingtin plays a protecti...
Autores principales: | Arribat, Yoan, Bonneaud, Nathalie, Talmat-Amar, Yasmina, Layalle, Sophie, Parmentier, Marie-Laure, Maschat, Florence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701666/ https://www.ncbi.nlm.nih.gov/pubmed/23861941 http://dx.doi.org/10.1371/journal.pone.0068775 |
Ejemplares similares
-
Systemic delivery of P42 peptide: a new weapon to fight Huntington’s disease
por: Arribat, Yoan, et al.
Publicado: (2014) -
Vesicular Axonal Transport is Modified In Vivo by Tau Deletion or Overexpression in Drosophila
por: Talmat-Amar, Yasmina, et al.
Publicado: (2018) -
Control of the structural landscape and neuronal proteotoxicity of mutant Huntingtin by domains flanking the polyQ tract
por: Shen, Koning, et al.
Publicado: (2016) -
Amyloid modifier SERF1a interacts with polyQ-expanded huntingtin-exon 1 via helical interactions and exacerbates polyQ-induced toxicity
por: Tsai, Tien-Ying, et al.
Publicado: (2023) -
Length-Dependent Structural Transformations of Huntingtin PolyQ Domain Upon Binding to 2D-Nanomaterials
por: Feng, Mei, et al.
Publicado: (2020)